(Alliance News) - The follow is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:
----------
Silence Therapeutics PLC - Chief Financial Officer Rob Quinn sells 89,054 shares at average GBP4.04, worth GBP359,778, on Thursday last week and Monday.
----------
Jardine Matheson Holdings Ltd - Finance Director John Witt buys 22,000 shares at USD44.09, worth USD970,083, on Monday.
----------
Metro Bank PLC - Chair Michael Snyder, directly and via Carey Pensions UK LLP, buys 96,700 shares at GBP0.78, worth GBP75,786, on Monday.
----------
Genedrive PLC - Chief Executive Officer David Budd buys 25,000 shares, while Non-Executive Chair Ian Gilham and CFO Matthew Fowler each by 12,500 shares, at 80p, spending a total of GBP40,000, as part of the broker option for the molecular diagnostics firm share issue. Genedrive raised GBP7.0 million in a share placing last week and said Tuesday it raised a further GBP1.0 million in the oversubscribed broker option conducted by Peel Hunt and finnCap. The broker option allowed private investors to participate in Genedrive's equity raise.
----------
EPE Special Opportunities Ltd - Directors Heather Bestwick and David Pirouet buy 1,250 and 2,912 shares, respectively, while Giles Brand, managing partner of investment advisor EPIC Private Equity LLP, buys 23,500 shares, all at 160.00p and together worth GBP44,259, on Monday.
----------
Devro PLC - Non-Executive Director Malcolm Swift buys 10,000 shares at GBP1.69, worth GBP15,995, on Tuesday.
----------
Share PLC - India Thomas and Dylan Thomas, associated with Non-Executive Director Gareth Thomas, buy 47,760 shares at 33.5p, worth GBP16,000, on Monday. Gareth Thomas now is interested in 466,180 shares, 0.3% of the total.
----------
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Jardine Math.sr (JAR)
Genedrive (GDR)
Metro Bank (MTRO)
Epe Special Opp (ESO)